The PD-L1/4-1BB Bispecific Antibody-Anticalin Fusion Protein PRS-344/S095012 Elicits Strong T-Cell Stimulation in a Tumor-Localized Manner.

Purpose: While patients responding to checkpoint blockade often achieve remarkable clinical responses, there is still significant unmet need due to resistant or refractory tumors. A combination of checkpoint blockade with further T-cell stimulation mediated by 4-1BB agonism may increase response rates and durability of response. A bispecific molecule that blocks the programmed cell death 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) axis and localizes 4-1BB costimulation to a PD-L1-positive (PD-L1+) tumor microenvironment (TME) or tumor draining lymph nodes could maximize antitumor immunity and increase the therapeutic window beyond what has been reported for anti-4-1BB mAbs.

The insecticidal toxin genes of Yersinia enterocolitica are activated by the thermolabile LTTR-like regulator TcaR2 at low temperatures.

Temperature-dependent activation of bacterial virulence factors at 37°C is well investigated. The molecular mechanism underlying the expression of toxicity determinants at environmental temperatures, however, has not been characterized. The insecticidal activity of Yersinia enterocolitica strain W22703 requires the toxin complex subunit A (TcaA) encoded on the pathogenicity island Tc-PAIYe .

Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity.

Purpose: Following two cases of neutralizing antibodies to epoetin alfa in an investigational clinical study, a small number of individual syringes of two drug product batches were found to contain unusually high levels of aggregation at the end of the clinical trial.

Methods: We undertook an extensive analytical approach to determine the root-cause of the increased aggregation in the affected batches.

Results: Soluble tungsten was found in the syringes, most likely derived from the pins used to manufacture the syringes.